Assenagon Asset Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-131,020
| Closed | -$97K | – | 1482 |
|
|
2022
Q2 | $97K | Buy |
131,020
+107,897
| +467% | +$79.9K | ﹤0.01% | 1362 |
|
|
2022
Q1 | $201K | Buy |
+23,123
| New | +$201K | ﹤0.01% | 1308 |
|
|
2021
Q2 | – | Sell |
-181,578
| Closed | -$2.67M | – | 1352 |
|
|
2021
Q1 | $2.67M | Buy |
181,578
+57,793
| +47% | +$851K | 0.01% | 619 |
|
|
2020
Q4 | $2.4M | Buy |
+123,785
| New | +$2.4M | 0.01% | 452 |
|